$SRNE

Sorrento Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$6.42 ▼-0.465%

Extented Hours

VOLUME

3,920,956

DAY RANGE

6.29 - 6.54

52 WEEK

5.17 - 17.25

Join Discuss about SRNE with like-minded investors

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Friday, August 20, 2021 Futures Up/Down % Last Dow -121.00 0.35% 34,697 S&P 500 -16.25 0.36% 4,385 Nasdaq -28.50 0.19% 14,899 Global stock markets are lower again as investors grapple with the spread of the highly contagious COVID-19 delta variant, the impact of the virus on growth and China’s continued crackdown on its technology sector. All eyes on next week’s Federal Reserve’s Jackson Hole symposium where comments on inflation, bond asset purchase tapering will be closely watched. The dollar rose for a fifth day, while Treasury yields continued a slide. Oil prices are currently lower, on track for a 7-day losing streak (longest decline wince 2019) while the U.S. dollar is set for its biggest weekly gain since June (weighing again on commodity prices), currently up at 9 ½ month highs around 93.65 for the dollar index (DXY) with Sept 2020 highs around 94.74. In vaccine news, the Washington Post reported that U.S. health officials are investigating reports that Moderna Inc’s ($MRNA) COVID-19 vaccine may be linked to a higher risk of a rare heart condition in younger adults than previously thought, sending shares lower. In Asian markets, more regulatory concerns/measures crippling stocks as the Nikkei Index slides -267 points (about 1%) to settle at 27,013, the Shanghai Index fell -38 points or 1.1% to close at 3,427 and the Hang Seng Index plunged -466 points or 1.84% to end the week at 24,849. In Europe, the German DAX is down around -70 points (-0.45%) to drop below 15,700, while the FTSE 100 slip about -10 points to 7,045. Stocks finished a choppy Thursday session mixed on concerns the Federal Reserve could begin tapering stimulus this year, even as surging coronavirus infections caused by the delta variant raised worries about the pace of the U.S. recovery. In the bond market, the 10-year Treasury yield at 1.23%. The Russell 2000 SmallCap index pointing to a lower open, entering today with a 6-day losing streak. Market Closing Prices Yesterday The S&P 500 Index climbed 5.53 points, or 0.13%, to 4,405.80 The Dow Jones Industrial Average fell -66.57 points, or 0.19%, to 34,894.12 The Nasdaq Composite gained 15.87 points, or 0.11%, to 14,541.79 The Russell 2000 Index declined -26.36 points, or 1.22% to 2,132.42 Events Calendar for Today 1:00 PM EST Baker Hughes Weekly rig count data Earnings Calendar: Earnings Before the Open: BKE, DE, FL Macro Up/Down Last Nymex -0.47 63.22 Brent -0.48 65.97 Gold 3.70 1,784.10 EUR/USD 0.0006 1.1681 JPY/USD -0.12 109.62 10-Year Note +0.01 1.233% World News Germany July PPI +1.9% MoM vs. +0.8% consensus and rose +10.4% YoY vs. 9.2% consensus UK Jul Retail Sales miss falling -2.5% MoM vs 0.4% consensus and rose +2.4% YoY vs 6.0% consensus; core m/m fell -2.4% vs 0.3% consensus and on a YoY basis, rose +1.8% vs 5.7% consensus Consumer confidence in the U.K. edged down in August but remained at pre-pandemic levels, market-research company GfK said Friday. GfK’s consumer-confidence indicator came in at minus 8 in August, down one point from July vs, forecast an unchanged reading at minus 7. Sector News Breakdown Consumer Farfetch Limited ($FTCH) Q2 EPS loss (-$0.17) vs. est. loss (-$0.33); Q2 revs $523.3M vs. est. $496.8M; Q2 Gross Merchandise Value exceeds $1 billion, up 40% YoY and more than double compared to Q2 2019; full-price sales growth of 90% drives Q2 2021 Digital Platform GMV; Q2 2021 gross profit margin improves by 30 bps year-over-year to 44% Ross Stores ($ROST) 2Q EPS $1.39 vs est. $0.98 on sales $4.8B vs est. $4.5B, comps +15%; sees 3Q comps +5-7% with EPS $0.61-0.69 vs est. $0.93; guides FY EPS $4.20-4.38 vs est. $4.40 on comps +10-11% Macy’s ($M) upgraded to Neutral from Underweight with $25 tgt at JPMorgan Adtalem Global Education Inc. ($ATGE) 4Q adj EPS $0.70 on revs $280.4Mm vs est. $283.4Mm; guides FY22 revs $1.685-1.735B vs est. $1.2B, sees FY22 adj EPS $4.20-4.45 vs est. $3.30 Major League Baseball and the Major League Baseball Players Association have struck new exclusive baseball card agreements with a new company controlled by online sports-merchandise retailer Fanatics Inc., breaking the decades-long grip that Topps Co. ($MUDS) has held on the trading-card market, people familiar with the matter said. https://on.mktw.net/3AX9qSN Tesla ($TSLA) CEO Elon Musk said the electric-vehicle company plans to adapt the artificial intelligence technology it has been developing for autonomous driving to make humanoid robots Energy, Industrials & Materials Deere ($DE) Q3 EPS $5.32 vs. est. $4.58; Q3 revs $11.52B vs. est. $10.3B; full-year earnings forecast raised to range of $5.7B-$5.9B vs. prior guidance of $5.3B-$5.7B; says looking ahead, we expect demand for farm and construction equipment to continue benefiting from favorable fundamentals; sees 2021 production & precision ag net sales up 25 to 30%, 2021 small ag & turf net sales up about 25% Financials Coinbase ($COIN) CEO Brian Armstrong tweeted: “We recently received board approval to purchase over $500M of crypto on our balance sheet to add to our existing holdings. And we’ll be investing 10% of all profit going forward in crypto. I expect this percentage to keep growing over time as the crypto-economy matures. Cboe Global Markets ($CBOE) increases dividend 14% to 48c per share LPL Financial LLC ($LPLA) July total advisory and brokerage assets at the end of July were approximately $1.13 trillion, an increase of $17.6B, or 1.6%, compared to the end of June 2021; total net new assets for July were $10.0B, translating to an 11.5% annualized growth rate The Charles Schwab Corporation ($SCHW) said it is implementing a special five percent pay increase for employees “in recognition of their unwavering service to clients and each other throughout the pandemic Healthcare S. health officials are investigating reports that Moderna Inc’s (MRNA) COVID-19 vaccine may be linked to a higher risk of a rare heart condition in younger adults than previously thought, the Washington Post reported late on Thursday https://reut.rs/3z3wKxP AstraZeneca PLC ($AZN) said Friday it would seek regulatory approval for an antibody drug after a study showed strong efficacy in preventing symptomatic Covid-19, offering a potential new alternative to vaccines for people who refuse shots or for whom they aren’t effective. The company said AZD7442 showed 77% efficacy in reducing risk of symptomatic Covid-19 compared with a placebo in late-stage clinical trials testing its usefulness as a preventive treatment Johnson & Johnson ($JNJ) said that Joaquin Duato, vice chairman of the company’s executive committee, will become CEO on Jan. 3, with Chairman and Chief Executive Alex Gorsky transitioning to executive chairman. Gorsky has served as the company’s chairman and CEO for nearly a decade, and has been with Johnson & Johnson for 30 years. “ Fate Therapeutics ($FATE) announces positive interim clinical data from its FT596 and FT516 off-the-shelf, IPSC-derived NK cell programs for b-cell lymphoma; 10 of 14 Patients in FT596 single-dose escalation cohorts 2 and 3 achieved objective response; 7 patients achieved complete response, including 2 of 3 patients treated with FT596 in combination with Rituximab following autologous CD19 CAR T-cell therapy Sorrento ($SRNE) announces its lead protein-based covid-19 vaccine candidate – dyai-100 – elicits strong neutralizing immune responses in vaccinated animals against sars-cov-2 and multiple major variants of concern Technology, Media & Telecom Applied Materials ($AMAT) 3Q adj EPS $1.90 vs est. $1.77 on revs $6.2B vs est. $5.94B; guides 4Q net sales approx $6.33B +/- $250Mm vs est. $6.04B, sees 4Q adj EPS $1.87-2.01 vs est. $1.81 Adobe Systems ($ADBE) to acquire Io in a transaction, valued at $1.275B Spotify Technology ($SPOT) has authorized to repurchase 10M company’s ordinary shares, up to the amount of $1B Marin Software ($MRIN) enters $50M equity distribution agreement S. listed China shares active amid yet more regulatory pressure headlines; the country approved a strict data privacy law, triggering fresh concerns over the intensity of Beijing’s recent regulatory crackdowns. The Personal Information Protection Law was passed at a meeting in Beijing of the nation’s top legislative body, the Standing Committee of the National People’s Congress. Apple ($AAPL) delays office return to at least January on Covid rise, while IBM closes New York City offices amid rising covid-19 cases A new round of proposed regulations sent Alibaba Group Holding Ltd. ’s ($BABA)S. listing to decline 4.9% on Tuesday to $173.73, its lowest close since October 2019. The Chinese tech company’s American depository receipts have fallen more than 25% so far this year. New draft guidelines released Tuesday by China’s top market regulator aim to prevent internet companies from adopting forced exclusivity and blocking competitors’ links and apps

85 Replies 15 👍 11 🔥

profile
@HeyShoe #droscrew
recently

RECAP 8/9 Chatter: $MCMJ + $LFLY SPAC $QLYS + Buys TotalCloud $GPRO $AMZN + Counterfeiter lawsuit $PENN + MLB Broadcast talks $MCD - Italian Franchise Anti-trust $SRNE + COVID Vax

85 Replies 8 👍 9 🔥

profile
@dros #droscrew
recently

*Sorrento: Publication Details 'Promising Results' About Salicyn-30 and Other Salicylanilides in Reducing SARS-CoV--2 Replication and Suppressing Induction of Inflammatory Cytokines in Rodent Model $SRNE

150 Replies 14 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

$SRNE going

135 Replies 11 👍 15 🔥

profile
@CarlosH #ivtrades
recently

$SRNE 15C next week

57 Replies 8 👍 15 🔥

profile
@viking #StockTraders.NET
recently

SRNE has just a stack of PRs in the drawer for whenever them want them

81 Replies 11 👍 9 🔥

profile
@viking #StockTraders.NET
recently

SRNE Receives EUA Approval and Import License from Mexico Authority COFEPRIS for COVI-STIX™ (COVID-19 Virus Rapid Antigen Detection Test); Plans Product Launch with Initial Shipments in July

85 Replies 9 👍 12 🔥

profile
@Navneet #droscrew
recently

$srne 20 calls jan 2022 0.75

53 Replies 7 👍 11 🔥

profile
@dros #droscrew
recently

Unusually active option classes on open June 14th $CRSR $STAY $RAPT $BIGC $SRNE $NVAX $BMBL $CRON $SOS $VXRT

65 Replies 9 👍 9 🔥

profile
@dros #droscrew
recently

Unusually active option classes on open June 14th $CRSR $STAY $RAPT $BIGC $SRNE $NVAX $BMBL $CRON $SOS $VXRT

60 Replies 14 👍 11 🔥

XX
@xX_Drip_Gawd_Xx #StockTraders.NET
recently

$SRNE going

110 Replies 10 👍 10 🔥

profile
@HeyShoe #droscrew
recently

RECAP 5/25 Chatter: $PRVB + Teplizumab Briefing Docs The Athletic + $NYT $MU - Cautious NAND Comments $AMZN - DC AG Antitrust $CCIV + Reveal tomorrow $CERN + $ORCL (Betaville) $TWTR + Shopping $SRNE + COVI-Drops $EH + Longe Range AAV $RVP + US Funding

140 Replies 14 👍 12 🔥

profile
@Math #StockTraders.NET
recently

I got SRNE on smaller size

147 Replies 10 👍 6 🔥

profile
@HeyShoe #droscrew
recently

RECAP 4/9 Chatter: $SRNE + Ztlido approval $BNTX $PFE + 1.8B EU Doses $BA - 90 plane MAX issue $NIU + RQi Electric motorcycle $IHRT + FCC COnsidering GMEI Foreign equity interest $CS + $BLK $STT Asset mgmt unit $BNTX $PFE + Seeks adolescent EUA $NIO + 100K production goal

117 Replies 13 👍 12 🔥

profile
@PradeepB #droscrew
recently

srne cldr are next and tomorrow this continues

55 Replies 9 👍 6 🔥

SU
@sulleytrim #LWT Trading
recently

I hope you guys got in on some of the action on SRNE when I called it out earlier 🚀

131 Replies 9 👍 12 🔥

DR
@dramdram #ivtrades
recently

who was it that told me every dog has his day regarding $SRNE .

99 Replies 6 👍 6 🔥

AN
@andres168 #StockTraders.NET
recently

SRNE crazyness

53 Replies 7 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

new highs on $srne

57 Replies 8 👍 12 🔥

AN
@andres168 #StockTraders.NET
recently

$srne 15.5 looking good

82 Replies 11 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

$SRNE starting to go

123 Replies 12 👍 8 🔥

GM
@gman2 #ivtrades
recently

out $SRNE Mar 30 Calls + 650%

108 Replies 11 👍 10 🔥

AN
@andres168 #StockTraders.NET
recently

im shor t$srne

48 Replies 8 👍 7 🔥

AN
@andres168 #StockTraders.NET
recently

srne is just squeez

142 Replies 10 👍 8 🔥

GM
@gman2 #ivtrades
recently

still holding $SRNE Mar 30 Calls

84 Replies 7 👍 12 🔥

GM
@gman2 #ivtrades
recently

out $SRNE Feb 10 Calls +200%

134 Replies 7 👍 9 🔥

GM
@gman2 #ivtrades
recently

$SRNE squeeze continues

64 Replies 11 👍 12 🔥

SU
@sulleytrim #LWT Trading
recently

SRNE just dropped really good news. Here’s the headline: Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients

101 Replies 8 👍 11 🔥

profile
@Benlax #droscrew
recently

f fcel uber srne nndm wkhs gm blnk tme all sold

95 Replies 7 👍 6 🔥

GM
@gman2 #ivtrades
recently

$SRNE IV exploded 140%

121 Replies 6 👍 11 🔥

profile
@CarlosH #ivtrades
recently

1,000 $SRNE 100 (Weeklys) 12 FEB 21 14 CALL @.45 LMT

105 Replies 12 👍 11 🔥

GM
@gman2 #ivtrades
recently

$SRNE short squeeze 32% short float

78 Replies 6 👍 9 🔥

DR
@dramdram #ivtrades
recently

SRNE is an old dog with flees lol Even the flees have names its so old.

44 Replies 12 👍 15 🔥

GM
@gman2 #ivtrades
recently

on Tuesday $SRNE Mar 30's had the highest IV of all equity options

81 Replies 15 👍 8 🔥

GM
@gman2 #ivtrades
recently

Carlos, who raised $SRNE to $35?

61 Replies 14 👍 10 🔥

profile
@dros #droscrew
recently

you wanna buy both and open a straddle? > @rohang said: $SRNE for Jan 22 - $10 call and put.. is it good?

87 Replies 13 👍 13 🔥

profile
@CarlosH #ivtrades
recently

$SRNE raised to $35

40 Replies 15 👍 10 🔥

profile
@RohanG #droscrew
recently

$SRNE for Jan 22 - $10 call and put.. is it good?

93 Replies 11 👍 6 🔥

GM
@gman2 #ivtrades
recently

H.C. Wainwright analyst rates $SRNE a buy with a $30 price target

145 Replies 10 👍 13 🔥

GM
@gman2 #ivtrades
recently

$SRNE 30% short float

74 Replies 7 👍 7 🔥

profile
@ivtrades-Chris #ivtrades
recently

SWEEP DETECTED: >>2899 $SRNE Jan 2021 9.0 Calls trade $1.15 (FT Theo=1.06) ASKSIDE [MULTI] 14:20:09 IV=141.0% +15.9 ISO Vol=5949, OI=3854

79 Replies 6 👍 11 🔥

MB
@MB-2020 #ivtrades
recently

$SRNE is going up slowly

84 Replies 9 👍 12 🔥

profile
@Navneet #droscrew
recently

$srne 10 c jan 2021 1.00

141 Replies 13 👍 6 🔥

profile
@thegiz18 #ivtrades
recently

$SRNE big jump

58 Replies 12 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

basically all covered $SRNE swing

90 Replies 13 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

$SRNE slow death

108 Replies 6 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

$SRNE will also look to cover too

124 Replies 13 👍 10 🔥

profile
@viking #StockTraders.NET
recently

that "partnership" with columbia unversity legitimized this company for many people. they dont realize it was just columbia offloading a worthless product > @Armm5 said: $SRNE , they never learn

125 Replies 7 👍 12 🔥

profile
@Armm5 #StockTraders.NET
recently

$SRNE , they never learn

65 Replies 14 👍 8 🔥

profile
@viking #StockTraders.NET
recently

$SRNE Press

56 Replies 10 👍 7 🔥

Key Metrics

Market Cap

1.95 B

Beta

0.29

Avg. Volume

5.05 M

Shares Outstanding

302.95 M

Yield

0%

Public Float

0

Next Earnings Date

2021-11-05

Next Dividend Date

Company Information

Sorrento is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases. Sorrento's multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as fully human antibodies ('G-MAB™library'), clinical stage immuno-cellular therapies ('CAR-T', 'DAR-T'), antibody-drug conjugates ('ADCs'), and clinical stage oncolytic virus ('Seprehvir®'). Sorrento is also developing potential coronavirus antiviral therapies and vaccines, including COVIDTRAP™, ACE-MAB™, COVI-MAB™, COVI-GUARD™, COVI-SHIELD™and COVI-CELL™. Sorrento's commitment to life-enhancing therapies for patients is also demonstrated by its effort to advance a first-in-class (TRPV1 agonist) non-opioid pain management small molecule, resiniferatoxin ('RTX'), and ZTlido® (lidocaine topical system) 1.8% for the treatment of post-herpetic neuralgia. RTX is completing a phase IB trial for intractable pain associated with cancer and a phase 1B trial in osteoarthritis patients. ZTlido® was approved by the FDA on February 28, 2018.

CEO: Henry Ji

Website:

HQ: 4955 Directors Pl San Diego, 92121 California

Related News